Narcolepsy-like symptoms in a patient with down syndrome and without obstructive sleep apnea

Sleep

Volumn 26, Issue 3, 2003, Pages 285-286

  Dominguez Ortega, Luis ^a,b   Salin Pascual, Rafael J ^c   Díaz Gállego, Elena ^b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b Unidad de Sueño   (Spain)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Down syndrome; Narcolepsy; Rapid eye movement sleep; Sleep

Indexed keywords

LORAZEPAM; VALPROIC ACID; VIGABATRIN; ANTICONVULSIVE AGENT;

ADULT; ARTICLE; CASE REPORT; CATAPLEXY; DIAGNOSTIC PROCEDURE; DOWN SYNDROME; DROWSINESS; EPILEPSY; FEMALE; GENETIC SCREENING; HLA TYPING; HUMAN; MEDICAL ASSESSMENT; NARCOLEPSY; PHARMACEUTICAL CARE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SEROLOGY; SLEEP; SLEEP APNEA SYNDROME; SLEEP DISORDER; DIFFERENTIAL DIAGNOSIS; PHYSIOLOGY; REM SLEEP;

ADULT; ANTICONVULSANTS; DIAGNOSIS, DIFFERENTIAL; DOWN SYNDROME; EPILEPSY; FEMALE; HUMANS; NARCOLEPSY; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE; SLEEP, REM;

EID: 0042853170     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/26.3.285     Document Type: Article

References (15)

1. Korenberg JR, Pulst SM, Gerwehr S. Advances in the understanding of chromosome 21 and Down syndrome. In: Lott IT, McCoy EE, eds. Down syndrome advances in medical care. New York: Wiley-Liss, 1992;3-13.
2. Grubar JC, Gigli GL, Colognola RM, Ferri R, Musemici SA, Bergonzi P. Sleep patterns of Down's syndrome children: effects of butoctamide hydrogen succinate (BAHS) administration. Psychopharmacology. 1986;90:19-22.
3. Marcus CL, Keens TH, Bautista DB, Von Pechmann WS, Ward D. Obstructive sleep apnea in children with Down syndrome Pediatrics 1991;88:132-9
4. Southall DP, Stebbens VA, Mirza R, Lang MH, Croft CB, Shinebourne EA. Upper airway obstruction with hypoxemia and sleep disruption in Down syndrome. Dev Med Child Neurol 1987;29:734-42.
5. Stebbens VA, Dennis J, Samuels MP, Croft CB, Southall DP. Sleep-elated upper airway obstruction in a cohort with Down's syndrome. Arch Dis Child 1991;66:1333-8.
6. de Miguel Díez J, Villa Asensi JR, Alvarez-Sala JL. Características del síndrome de apnea obstructiva del sueño en pacientes con un síndrome de Down. Arch Bronconeumol 2002;38:77-80.
7. Guilleminault Ch, Anagnos A. Narcolepsy. In: Kryger MH, Roth T, Dement WC, eds. Principles and practice of sleep medicine. Philadelphia: WB Saunders, 2000;676-86.
8. Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999;98:365-76.
9. Nishino S, Ripley B, Overeem S, et al. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40.
10. Thannickal TC, Moore RY, Nienhuis R, et al Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27:469-74.
11. Stalh SM, Layzer RB, Aminoff MJ, Townsend JJ, Feldon S. Continuous cataplexy in a patient with a midbrain tumor: the limp man syndrome. Neurology 1980;30:1115-9.
12. Schoenhuber R, Angiari P, Peserico L. Narcolepsy symptomatic of a pontine glioma. Ital J Neurol Sci 1981;4:379-80.
13. Erlich SS, Itabushi HH. Narcolepsy, a neuropathologic study. Sleep. 1986;9:126-132.
14. Rechtschaffen A, Kales A, eds. A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. Los Angeles: UCLA Brain Information Service/Brain Research Institute; 1968.
15. International classification of sleep disorders: diagnostic and coding manual. Rochester: American Sleep Disorders Association; 1990.